Leidos (NYSE:LDOS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday.

According to Zacks, “Leidos Holdings, Inc. (Leidos) is a holding company whose direct 100%-owned subsidiaries and principal operating companies are Leidos, Inc. and Leidos Innovations Corporation. Leidos is a global science and technology company that provides technology and engineering services and solutions in the defense, intelligence, civil and health markets. Their domestic customers include agencies of the U.S. Department of Defense, the U.S. Intelligence Community, the U.S. Department of Homeland Security, the Federal Aviation Administration, the Department of Health and Human Services, other U.S. Government civil agencies and state and local government agencies. Their international customers include foreign governments and their agencies, primarily located in the United Kingdom, the Middle East and Australia. “

Other equities analysts also recently issued reports about the stock. TheStreet raised shares of Leidos from a “c+” rating to a “b+” rating in a research report on Monday, October 2nd. Cowen reissued a “buy” rating and set a $68.00 target price on shares of Leidos in a research report on Thursday, October 12th. Jefferies Group reissued a “buy” rating and set a $75.00 target price on shares of Leidos in a research report on Thursday, October 5th. BidaskClub raised shares of Leidos from a “hold” rating to a “buy” rating in a research report on Wednesday, September 27th. Finally, Citigroup increased their target price on shares of Leidos from $65.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $69.33.

Leidos (NYSE LDOS) traded up $0.86 during midday trading on Tuesday, hitting $67.44. 769,550 shares of the stock were exchanged, compared to its average volume of 793,464. Leidos has a 1-year low of $47.81 and a 1-year high of $67.46. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.27 and a quick ratio of 1.03. The firm has a market capitalization of $10,070.00, a P/E ratio of 36.06, a PEG ratio of 1.70 and a beta of 1.66.

Leidos (NYSE:LDOS) last posted its quarterly earnings results on Thursday, November 2nd. The aerospace company reported $0.95 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.14. The business had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.55 billion. Leidos had a net margin of 3.04% and a return on equity of 17.20%. Leidos’s revenue for the quarter was up 34.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.25 earnings per share. analysts anticipate that Leidos will post 3.7 EPS for the current fiscal year.

In other news, Director John P. Jumper sold 61,212 shares of the firm’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $64.06, for a total value of $3,921,240.72. Following the sale, the director now directly owns 306,709 shares of the company’s stock, valued at $19,647,778.54. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.70% of the company’s stock.

Several large investors have recently modified their holdings of LDOS. Schwab Charles Investment Management Inc. grew its position in shares of Leidos by 5.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 460,871 shares of the aerospace company’s stock valued at $23,823,000 after purchasing an additional 22,717 shares during the last quarter. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Leidos in the second quarter valued at about $340,000. Westpac Banking Corp grew its position in shares of Leidos by 15.7% in the second quarter. Westpac Banking Corp now owns 12,508 shares of the aerospace company’s stock valued at $647,000 after purchasing an additional 1,697 shares during the last quarter. Oppenheimer Asset Management Inc. grew its position in shares of Leidos by 263.0% in the second quarter. Oppenheimer Asset Management Inc. now owns 3,111 shares of the aerospace company’s stock valued at $161,000 after purchasing an additional 2,254 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in shares of Leidos by 0.4% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 20,940 shares of the aerospace company’s stock valued at $1,082,000 after purchasing an additional 75 shares during the last quarter. 73.48% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://www.dailypolitical.com/2018/01/11/leidos-ldos-lowered-to-hold-at-zacks-investment-research.html.

Leidos Company Profile

Leidos Holdings, Inc (Leidos) is a science and technology solutions company focused on delivering solutions primarily in the areas of national security, health and engineering. The Company is a holding company whose direct 100%-owned subsidiary is Leidos, Inc, which delivers science and technology solutions in the areas of national security, health and engineering to agencies of the United States Department of Defense (DoD), the intelligence community, the United States Department of Homeland Security, and other United States Government civil agencies, state and local government agencies, foreign governments and customers across a variety of commercial markets.

Get a free copy of the Zacks research report on Leidos (LDOS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Leidos (NYSE:LDOS)

Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.